Home/Filings/4/0000950170-23-068812
4//SEC Filing

Bryce Joanne 4

Accession 0000950170-23-068812

CIK 0001816736other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 4:15 PM ET

Size

15.6 KB

Accession

0000950170-23-068812

Insider Transaction Report

Form 4
Period: 2023-12-05
Bryce Joanne
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-12-05$1.01/sh+755$7635,041 total
  • Sale

    Common Stock

    2023-12-05$56.55/sh1,293$73,1152,600 total
  • Sale

    Common Stock

    2023-12-05$57.06/sh100$5,7062,500 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-12-055260 total
    Exercise: $1.01Exp: 2029-11-05Common Stock (526 underlying)
  • Exercise/Conversion

    Common Stock

    2023-12-05$1.01/sh+526$5314,286 total
  • Sale

    Common Stock

    2023-12-05$55.29/sh1,148$63,4783,893 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-12-05755752 total
    Exercise: $1.01Exp: 2029-11-05Common Stock (755 underlying)
Footnotes (5)
  • [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.93 to $55.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.05 to $57.04, inclusive.
  • [F4]The shares underlying this option are fully vested and exercisable as of the date hereof.
  • [F5]The shares underlying this option vest in 16 equal quarterly installments following May 1, 2020, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file

Issuer

Disc Medicine, Inc.

CIK 0001816736

Entity typeother

Related Parties

1
  • filerCIK 0001951845

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:15 PM ET
Size
15.6 KB